⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 5, 2015Annals of Internal Medicine

Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Roche Laboratories.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Boeckh et al. (2015) studied this question.

synapsesocial.com/papers/69dcc790a5c75be4cfe54329 https://doi.org/10.7326/m13-2729

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Extended routine polymerase chain reaction surveillance and pre‐emptive antiviral therapy for cytomegalovirus after allogeneic transplantationCohort Study · 2000 · 59 citations
2Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupOriginal Research · 2008 · 4,956 citations
3Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled studyRCT · 2005 · 255 citations
4Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsHuman Clinical Trial · 2002 · 1,244 citations
5Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivationOriginal Research · 2003 · 250 citations